Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
17
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
national top stories
san francisco blog main
startups
deals
fda
san diego blog main
san diego top stories
raleigh-durham blog main
san francisco top stories
new york blog main
raleigh-durham top stories
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical device
national
new york top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
glaxosmithkline
investing
san diego
sanofi
alexion pharmaceuticals
autoimmune disorders
What
disease
17
×
drug
medicines
new
called
companies
control
potential
research
roundup
therapeutics
year
according
adds
ago
alzheimer's
bio
cancer
centers
deal
diseases
drugs
established
fda
fight
gene
hepatitis
infections
infectious
known
liver
lung
million
nash
news
pharma
pharmaceuticals
proteins
race
rare
Language
unset
Current search:
biotech
×
disease
×
@extremetech.com
1 year ago
Potential Research Fabrication Bombshell Threatens Amyloid Theory of Alzheimer’s Disease
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
4 years ago
California Life Sciences Fueled by Education, Established Companies
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@techcrunch.com
5 years ago
HP is ‘printing’ drugs for the CDC to speed up antibiotic testing
@techcrunch.com
5 years ago
RDMD attacks rare diseases with data mined from health records
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed